Background: Cutaneous chronic graft versus host disease (GVHD) is a severe complication …
Patients were treated with psoralen plus ultraviolet (PUVA)‐bath photochemotherapy three …

… Therefore, bath psoralen plus ultraviolet-A (PUVA) is an alternative … bath PUVA for managing
chronic graft-versus-host disease. … We analyzed the graft-versus-host disease clinical …

… Phototherapy has been applied for a variety of sclerosing skin diseases 19, 20 such as
eosinophilic fasciitis, chronic graft-vs.-host disease, lichen sclerosis et atrophicus and …

… involves the application of UV-A radiation after the patient has received a bath containing
psoralens diluted in water1 and, unlike traditional topical PUVA therapy, it allows us to treat …

… , chronic graft-versus-host disease, urticaria pigmentosa and nodular prurigo. … bath PUVA
therapy, while an interval of 15–30 minutes should be allowed between application of psoralen …

… may be applied topically [as soaks – whole‐body, except head and neck, in a bathwater
psoralen liquid (bath PUVA); as cream; as gel; as lotion] and by mouth (using different …

… Psoralen can be administered orally or in a solution applied to the skin (PUVA bath). There
were … The side-effects noted in the oral psoralen studies were not seen in the studies utilising …

… disease involving various types of chemokines regulating immune cell migration, localization,
and activation. Bath psoralen … psoriasis first treated with bath PUVA therapy between 2007 …

… The psoralen is usually applied as a dilute solution in a bath or in a small container for
local treatment of the hands and feet, the so-called soak PUVA therapy. Methoxsalen is the …

With the aim of obtaining new potential photochemotherapeutic agents, having increased
antiproliferative activity and decreased undesired effects, we have prepared some new …